Home Cart Sign in  
Chemical Structure| 68506-86-5 Chemical Structure| 68506-86-5

Structure of Vigabatrin
CAS No.: 68506-86-5

Chemical Structure| 68506-86-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Vigabatrin is a structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that irreversibly inhibits the catabolism of GABA by GABA transaminase.

Synonyms: γ-Vinyl-GABA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Vigabatrin

CAS No. :68506-86-5
Formula : C6H11NO2
M.W : 129.16
SMILES Code : C=CC(N)CCC(O)=O
Synonyms :
γ-Vinyl-GABA
MDL No. :MFCD00274577
InChI Key :PJDFLNIOAUIZSL-UHFFFAOYSA-N
Pubchem ID :5665

Safety of Vigabatrin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02205931 Epilepsy Phase 4 Recruiting June 2019 United Kingdom ... More >> Birmingham Children's Hospital Recruiting Birmingham, United Kingdom, B4 6NH Contact: Shakti Agrawal, MBBS    0044 1213338149    shakti.agrawal@bch.nhs.uk    Principal Investigator: Shakti Agrawal, MBBS          Bristol Royal Hospital for Children Recruiting Bristol, United Kingdom, BS2 8AE Contact: Andrew Mallick, FRCPCH          Principal Investigator: Andrew Mallick          Addenbrooke's Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Alasdair Parker, MA    0044 1223 245151    alasdair.parker@addenbrookes.nhs.uk    Principal Investigator: Alasdair Parker, MA          Lancashire Teaching Hospitals NHS Foundation Trust Recruiting Lancashire, United Kingdom Contact: Helen Basu       Helen.Basu@lthtr.nhs.uk    Principal Investigator: Helen Basu          Leeds Teaching Hospital Recruiting Leeds, United Kingdom, LS1 3EX Contact: Helen McCullagh, RCPCH    0044 113 243 2799    h.mccullagh@nhs.net    Principal Investigator: Helen McCullagh, RCPCH          Alder Hey Children's Hospital Recruiting Liverpool, United Kingdom, L12 2AP Contact: Rachel Kneen, BMBS    0044 151 2525163    rachel.kneen@liverpool.ac.uk    Principal Investigator: Rachel Kneen, BMBS          Great Ormond Street Hospital Recruiting London, United Kingdom, WC1N 3JH Contact: Christin Eltze, MD Res    0044 207 405 9200 ext 5438    christin.eltze@gosh.nhs.uk    Principal Investigator: Christin Eltze, MD Res          St George's University Hospitals NHS Foundation Trust Recruiting London, United Kingdom Contact: Penny Fallon       Penny.Fallon@stgeorges.nhs.uk    Principal Investigator: Penny Fallon          Royal Manchester Children's Hospital Recruiting Manchester, United Kingdom, M13 0JE Contact: Tim Martland, RCPCH    0044 161 276 1234    timothy.martland@cmft.nhs.uk    Principal Investigator: Tim Martland, RCPCH          The Newcastle Upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle upon Tyne, United Kingdom Contact: Anita Devlin       Anita.Devlin@nuth.nhs.uk    Principal Investigator: Anita Devlin          Sheffield Children's NHS Foundation Trust Recruiting Sheffield, United Kingdom Contact: Archana Desurkar       Archana.Desurkar@sch.nhs.uk    Principal Investigator: Archana Desurkar Less <<
NCT00552526 Epilepsy Ment... More >>al Retardation Less << Phase 4 Unknown December 2013 Norway ... More >> SSE, Nevrological dep. , Rikshospitalet University hospital Oslo, Norway Less <<
NCT03636958 Refractory Epilepsy Not Applicable Not yet recruiting December 2022 France ... More >> Assistance Publique Des Hopitaux de Marseille Not yet recruiting Marseille, Paca, France, 13354 Contact: STANISLAS LAGARDE, MD    +33 491385554    Stanislas.LAGARDE@ap-hm.fr Less <<
NCT01006811 Infantile Spasms Phase 2 Phase 3 Completed - India ... More >> All India Institute of Medical Sciences New Delhi, Delhi, India, 110049 Less <<
NCT01767779 - Active, not recruiting December 2018 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California UCLA Los Angeles, California, United States, 90095 United States, Massachusetts Boston Children's Hospital Boston, Massachusetts, United States, 02115 United States, Ohio Cincinnati Children's Hospital Cincinnati, Ohio, United States, 45229 United States, Texas University of Texas in Houston Houston, Texas, United States, 77030 Less <<
NCT01390909 - Completed - -
NCT01723787 - Active, not recruiting October 2018 United States, Colorado ... More >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 Less <<
NCT01390909 - Completed - -
NCT01549288 Infantile Spasms Phase 2 Phase 3 Withdrawn December 2013 India ... More >> Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital New Delhi, Delhi, India, 110001 Less <<
NCT00001489 - Completed - United States, Maryland ... More >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Less <<
NCT00626834 Cocaine Addiction Phase 1 Completed - United States, Texas ... More >> University of Texas Health Science Center San Antonio, Texas, United States, 78229 Less <<
NCT00527683 Cocaine Dependence Phase 2 Completed - Mexico ... More >> Clinica Integral de Tratamiento Contra las Adicciones SA de CV Mexico City, Mexico, D.F., Mexico, 11560 Less <<
NCT00506935 Methamphetamine Addiction Phase 1 Completed - United States, California ... More >> UCLA Los Angeles, California, United States, 90024 Less <<
NCT00611130 Cocaine Dependence Phase 2 Completed - United States, Arkansas ... More >> Addiction Treatment Clinic Little Rock, Arkansas, United States United States, California St. Luke's Hospital Addiction Pharmacology Research Laboratory San Francisco, California, United States, 94110 Friends Research Institute Torrance, California, United States United States, Florida Operation PAR Largo, Florida, United States Segal Institute for Clinical Research North Miami, Florida, United States, 33161 United States, Maryland Johns Hopkins Bayview Medical Center Center for Chemical Dependence Baltimore, Maryland, United States United States, Massachusetts Boston University School of Medicine Boston, Massachusetts, United States United States, New York New York University Mental Health and Addictive Disorders Research Program New York, New York, United States United States, Ohio Cincinnati Addiction Research Center (CinARC) Cincinnati, Ohio, United States Dayton Veterans Affairs Medical Center Dayton, Ohio, United States United States, Texas University of Texas Health Science Center at San Antonio San Antonio, Texas, United States Less <<
NCT00730522 Methamphetamine Dependence Phase 2 Terminated(To conserve remaini... More >>ng capital, Sponsor decided to terminate the study early.) Less << - United States, California ... More >> North County Clinical Research (NCCR) Oceanside, California, United States South Bay Treatment Center San Diego, California, United States Addiction Pharmacology Research Laboratory, St. Luke's Hospital San Francisco, California, United States United States, Missouri START Research and Treatment Kansas City, Missouri, United States United States, Nebraska Creighton University Medical Center Omaha, Nebraska, United States United States, New Mexico Behavioral Health Research Center of the Southwest Albuquerque, New Mexico, United States United States, Oklahoma Pahl Pharmaceutical Research Oklahoma City, Oklahoma, United States United States, Texas Pillar Research Dallas, Texas, United States Less <<
NCT00373581 Cocaine Dependence Phase 2 Terminated(Funding ran out) - United States, New York ... More >> Irving Center for Clinical Research New York, New York, United States, 10032 Less <<
NCT03421496 Infantile Spasm Phase 3 Recruiting December 2019 United States, Florida ... More >> Nicklaus Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Research Coordinator    786-624-3611    Abel.Ortega@Nicklaushealth.org    United States, Michigan Beaumont Children's Hospital Recruiting Royal Oak, Michigan, United States, 48073 Contact: Research Coordinator    248-551-3302    Elizabeth.Kring@beaumont.org    United States, Ohio Akron Children's Hospital Recruiting Akron, Ohio, United States, 44308 Contact: Research Coordinator    330-543-0690    jkatz@akronchildrens.org    United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Research Coordinator    503-418-8297    mccarbry@ohsu.edu    United States, Washington Institute for Research and Innovation | MultiCare Health System Recruiting Tacoma, Washington, United States, 98405 Contact: Research Coordinator    253-403-9348    ccanorro@multicare.org Less <<
NCT03003143 Autoimmune Encephalopathy Not Applicable Recruiting August 2018 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Kon Chu, Professor       stemcell.snu@gmail.com    Contact: JIN-SUN JUN, Fellow       junjinsun0401@gmail.com    Principal Investigator: Kon Chu, MD, PhD. Less <<
NCT00611130 - Completed - -
NCT01281202 Cocaine Addiction ... More >> Cocaine Dependence Less << Phase 2 Phase 3 Completed - United States, California ... More >> Matrix Institute on Addictions Los Angeles, California, United States, 90016 Friends Research Institute Torrance, California, United States, 90502 United States, Colorado VA Medical Center Denver, Colorado, United States, 80220 United States, Florida University of Miami School of Medicine Miami, Florida, United States, 33136 United States, Illinois NeuroPsychiatric Research & Practice Assoc., Ltd. Oak Brook, Illinois, United States, 60523 United States, Maryland Mountain Manor Treatment Center @ Baltimore Baltimore, Maryland, United States, 21229 United States, Massachusetts Boston University School of Medicine Boston, Massachusetts, United States, 02118 United States, New Mexico Pacific Institute for Research and Evaluation Albuquerque, New Mexico, United States, 87102 United States, Pennsylvania Western Psychiatric Inst. and Clinic Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29403 United States, Texas Pillar Clinical Research, LLC Dallas, Texas, United States, 75243 University of Texas Health Science Center at Houston Houston, Texas, United States, 77054 United States, Utah George E Wahlen VA Medical Center Salt Lake City, Utah, United States, 84148 Less <<
NCT01281202 - Completed - -
NCT01335867 Alcoholism Co... More >>caine Dependence Less << Phase 2 Terminated - United States, Pennsylvania ... More >> University of Pennsylvania, Treatment Research Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01278173 Adult Refractory Complex Parti... More >>al Seizures Less << Phase 4 Completed - -
NCT01335867 - Terminated - -
NCT01278173 - Completed - -
NCT01073579 - Completed - -
NCT02299115 Infantile Spasms Phase 3 Recruiting March 2021 Canada, Ontario ... More >> Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5G1X8 Contact: Cristina Go, MD    416-813-7353    cristina.go@sickkids.ca    Principal Investigator: Carter Snead, MD          Sub-Investigator: Kevin C Jones, MD          Sub-Investigator: Blathnaid McCoy, MD          Sub-Investigator: Ayako Ochi, MD          Sub-Investigator: Jennifer Boyd, RN,MSCN Less <<
NCT03347526 Infantile Spasm Phase 3 Enrolling by invitation August 2021 United States, Colorado ... More >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT01266291 - Terminated(Was not possible to... More >> enroll sufficient number of subjects to draw any worthwhile conclusions from the study.) Less << - -
NCT02849457 Tuberous Sclerosis Complex Phase 2 Recruiting May 2021 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35233 Contact: Jessica Krefting, RN    205-975-2890    jessicakrefting@uabmc.edu    Contact: Regina Ryan, MS    205-975-2890    reginaryan@uabmc.edu    Principal Investigator: E. Martina Bebin, MD, MPA          United States, California University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Natalie Solis    310-206-4037    nsolis@mednet.ucla.edu    Principal Investigator: Joyce Wu, MD          Children's Hospital of Orange County Recruiting Orange, California, United States, 92868 Contact: Shumyla Rashid    714-509-8642    srashid@choc.org    Principal Investigator: Mary Zupanc, MD          Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Swetapadma Patnaik    650-721-1458    sweta@stanford.edu    Principal Investigator: Brenda Porter, MD          United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Amelia Diplock    617-919-1476    amelia.diplock@childrens.harvard.edu    Principal Investigator: Mustafa Sahin, MD, PhD          United States, Michigan Beaumont Children's Hospital Recruiting Royal Oak, Michigan, United States, 48073 Contact: Emily Kreis, RN    248-551-2275    Emily.Kreis@beaumont.org    Principal Investigator: Danielle Nolan, MD          United States, Minnesota Minnesota Epilepsy Group, PA Recruiting Saint Paul, Minnesota, United States, 55102 Contact: Alisha Olson, RN    651-241-5206    aolson@mnepilepsy.net    Principal Investigator: Michael Frost, MD          United States, Missouri Washington University in St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Olga Novak    314-454-4267    novako@wustl.edu    Principal Investigator: Michael Wong, MD, PhD          United States, Ohio Cincinnati's Children Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Molly Griffith    513-636-9699    molly.griffith@cchmc.org    Principal Investigator: Darcy Kreuger, MD, PhD          United States, Pennsylvania The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Casey Gorman    267-426-5171    GormanC@email.chop.edu    Principal Investigator: Katherine Taub, MD          United States, Texas University of Texas Health Science Center at Houston Recruiting Houston, Texas, United States, 77054 Contact: Elida Salazar    713-500-5766    Elida.L.Salazar@uth.tmc.edu    Principal Investigator: Mary K Koenig, MD Less <<
NCT01585207 - Completed - -
NCT02220114 Infantile Spasms Not Applicable Completed - France ... More >> Service de neurologie pédiatrique - CHU Amiens, France, 80054 Service de neurologie pédiatrique - CHU Angers, France, 49033² Service de neuropédiatrie - CHU Pellegrin Enfants Bordeaux, France, 33076 Service de neurologie infantile - Hôpital Salengro Lille, France, 59037 Service de nuerologie pédiatrique - Hôpital Femme Mère Enfant Lyon, France, 69677 Service de neurologie pédiatrique - Hôpital de la Timone Marseille, France, 13385 Service de neurologie pédiatrique - Hôpital Necker Enfants Malades Paris, France, 75015 Service de neuropédiatrie - Hôpital Robert Debré Paris, France, 75019 Service de neurologie pédiatrique - Hôpital Sud Rennes, France, 35203 Centre référent des épilepsies rares pédiatrique associé - Hôpital de Hautepierre Strasbourg, France, 67098 Service de neuropédiatrie - Hôpital Purpan Toulouse, France, 331059 Service de neuropédiatrie - Hôpital de Clocheville Tours, France, 37044 Less <<
NCT01585207 Tourette's Disorder Phase 1 Phase 2 Completed - United States, New York ... More >> Tics and Tourette's Clinical and Research Program New York, New York, United States, 10029 Less <<
NCT01266291 Complex Partial Seizures Phase 4 Terminated(Was not possible to... More >> enroll sufficient number of subjects to draw any worthwhile conclusions from the study.) Less << - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT01413711 Infantile Spasms Phase 4 Withdrawn - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

7.74mL

1.55mL

0.77mL

38.71mL

7.74mL

3.87mL

77.42mL

15.48mL

7.74mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories